Schwannomatosis, which shows some clinical overlap with NF2 including development of multiple non-vestibular schwannomas, was subsequently defined as a distinct nosological entity in 2005 [12] and refined to include molecular diagnostic criteria in 2013 [13]. Here, NF2 is linked to schwannomatosis.